| 000 | 01388 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250514191928.0 | ||
| 264 | 0 | _c20050405 | |
| 008 | 200504s 0 0 eng d | ||
| 022 | _a1068-9265 | ||
| 024 | 7 |
_a10.1245/ASO.2004.11.025 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBerger, Adam C | |
| 245 | 0 | 0 |
_aUndetectable preoperative levels of serum CA 19-9 correlate with improved survival for patients with resectable pancreatic adenocarcinoma. _h[electronic resource] |
| 260 |
_bAnnals of surgical oncology _cJul 2004 |
||
| 300 |
_a644-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xpathology |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
| 650 | 0 | 4 |
_aCA-19-9 Antigen _xblood |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPancreatic Neoplasms _xpathology |
| 650 | 0 | 4 | _aPredictive Value of Tests |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aMeszoely, Ingrid M | |
| 700 | 1 | _aRoss, Eric A | |
| 700 | 1 | _aWatson, James C | |
| 700 | 1 | _aHoffman, John P | |
| 773 | 0 |
_tAnnals of surgical oncology _gvol. 11 _gno. 7 _gp. 644-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1245/ASO.2004.11.025 _zAvailable from publisher's website |
| 999 |
_c14903356 _d14903356 |
||